Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN) yesterday. The company’s shares closed last Monday at $0.28, close to its 52-week low of $0.25.
Vendetti observed:
“Yesterday, after the Market close, APDN reported better-than-expected F3Q19 (June) revenue, gross margin, and GAAP EPS compared to our estimates.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 3.9% and a 46.4% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Ellex Medical Lasers Limited, Restoration Robotics Inc, and Xtant Medical Holdings.
The the analyst consensus on Applied DNA Sciences is currently a Hold rating.
See today’s analyst top recommended stocks >>
The company has a one-year high of $1.84 and a one-year low of $0.25. Currently, Applied DNA Sciences has an average volume of 432.9K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion.
